Finally, and unexpectedly, we identified a “paradoxical” subgroup of CRC (n = 33/96 (34%)) that did not display any IFNγ response although they produced mature IL-18 and featured aCasp1+ tumor cells in 50% of cases. The gene discussed is IFNG; the disease is colorectal carcinoma.